HAE – haemonetics corporation (US:NASDAQ)
Stock Stats
News
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Haemonetics Is Still Undervalued, Even After The Rally [Seeking Alpha]
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
Haemonetics (NYSE:HAE) had its price target raised by analysts at Needham & Company LLC from $68.00 to $78.00. They now have a "buy" rating on the stock.
Form 4 HAEMONETICS CORP For: Nov 10 Filed by: KROLL MARK W
Form 10-Q HAEMONETICS CORP For: Sep 27
Form 8-K HAEMONETICS CORP For: Nov 06
Form 4 HAEMONETICS CORP For: Oct 31 Filed by: Galvin Roy
Form 4 HAEMONETICS CORP For: Sep 17 Filed by: Miller Laurie A.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.